ID

16664

Description

An Expanded Access Programme With Iressa for Patients With Non-Small-Cell Lung Cancer and Cancer of the Head and Neck; ODM derived from: https://clinicaltrials.gov/show/NCT00684385

Link

https://clinicaltrials.gov/show/NCT00684385

Keywords

  1. 7/30/16 7/30/16 -
Uploaded on

July 30, 2016

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :


No comments

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Non Small Cell Lung Cancer (NSCLC) DRKS00005552 NCT00684385

Eligibility Non Small Cell Lung Cancer (NSCLC) NCT00684385

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
have received at least one course of standard systemic chemotherapy or radiation therapy
Description

prior chemotherapy or radiation therapy

Data type

boolean

Alias
UMLS CUI [1]
C0279134
UMLS CUI [2]
C1514457
are ineligible for chemotherapy or radiotherapy
Description

ineligible for chemotherapy or radiotherapy

Data type

boolean

Alias
UMLS CUI [1,1]
C1512714
UMLS CUI [1,2]
C0392920
UMLS CUI [2,1]
C1512714
UMLS CUI [2,2]
C1522449
are ineligible or not candidates for enrollment in available zd1839 trials for nsclc or squamous cell h&nc
Description

ineligible for zd1839 trials

Data type

boolean

Alias
UMLS CUI [1,1]
C1512714
UMLS CUI [1,2]
C0879396
UMLS CUI [1,3]
C0008976
are, in the investigators opinion, not medically suitable for chemotherapy.
Description

not medically suitable for chemotherapy.

Data type

boolean

Alias
UMLS CUI [1,1]
C1512714
UMLS CUI [1,2]
C0392920
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
current eligibility (i.e., meeting the inclusion and exclusion criteria except signed informed consent) for any zd1839 protocol available to the patient, or previous enrollment in a blinded zd1839 protocol
Description

current eligibility for any zd1839 protocol

Data type

boolean

Alias
UMLS CUI [1,1]
C1512693
UMLS CUI [1,2]
C0879396
patients from a blinded protocol may be considered for acceptance, with astrazeneca's permission, only after trial completion and unblinding of all patients.
Description

study participation status

Data type

boolean

Alias
UMLS CUI [1]
C2348568
patients eligible for or previously enrolled in an open-label or unblinded zd1839 clinical trial may be considered for acceptance with astrazeneca's permission
Description

ID.7

Data type

boolean

Alias
UMLS CUI [1,1]
C2348568
UMLS CUI [1,2]
C1512693
UMLS CUI [1,3]
C0879396
incomplete healing from prior oncologic or other major surgery
Description

incomplete healing from prior oncologic or other major surgery

Data type

boolean

Alias
UMLS CUI [1]
C0151692

Similar models

Eligibility Non Small Cell Lung Cancer (NSCLC) NCT00684385

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
prior chemotherapy or radiation therapy
Item
have received at least one course of standard systemic chemotherapy or radiation therapy
boolean
C0279134 (UMLS CUI [1])
C1514457 (UMLS CUI [2])
ineligible for chemotherapy or radiotherapy
Item
are ineligible for chemotherapy or radiotherapy
boolean
C1512714 (UMLS CUI [1,1])
C0392920 (UMLS CUI [1,2])
C1512714 (UMLS CUI [2,1])
C1522449 (UMLS CUI [2,2])
ineligible for zd1839 trials
Item
are ineligible or not candidates for enrollment in available zd1839 trials for nsclc or squamous cell h&nc
boolean
C1512714 (UMLS CUI [1,1])
C0879396 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])
not medically suitable for chemotherapy.
Item
are, in the investigators opinion, not medically suitable for chemotherapy.
boolean
C1512714 (UMLS CUI [1,1])
C0392920 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
current eligibility for any zd1839 protocol
Item
current eligibility (i.e., meeting the inclusion and exclusion criteria except signed informed consent) for any zd1839 protocol available to the patient, or previous enrollment in a blinded zd1839 protocol
boolean
C1512693 (UMLS CUI [1,1])
C0879396 (UMLS CUI [1,2])
study participation status
Item
patients from a blinded protocol may be considered for acceptance, with astrazeneca's permission, only after trial completion and unblinding of all patients.
boolean
C2348568 (UMLS CUI [1])
ID.7
Item
patients eligible for or previously enrolled in an open-label or unblinded zd1839 clinical trial may be considered for acceptance with astrazeneca's permission
boolean
C2348568 (UMLS CUI [1,1])
C1512693 (UMLS CUI [1,2])
C0879396 (UMLS CUI [1,3])
incomplete healing from prior oncologic or other major surgery
Item
incomplete healing from prior oncologic or other major surgery
boolean
C0151692 (UMLS CUI [1])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial